NCT07400601 A Clinical Cohort Registry Study on Primary PCI for Acute Myocardial Infarction at Zhongshan Hospital
| NCT ID | NCT07400601 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shanghai Zhongshan Hospital |
| Condition | Acute Myocardial Infarction (AMI) |
| Study Type | OBSERVATIONAL |
| Enrollment | 6,000 participants |
| Start Date | 2026-02-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 6,000 participants in total. It began in 2026-02-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a registry-based cohort investigation, prospectively enrolling patients who were diagnosed with acute myocardial infarction and underwent primary percutaneous coronary intervention (PCI) at Zhongshan Hospital, Fudan University, between January 1, 2009, and December 31, 2028. Baseline clinical characteristics, procedural details, laboratory results, and medication records will be systematically collected and documented. The clinical follow-up will encompass both in-hospital monitoring and post-discharge surveillance extending up to two years after the procedure.
Eligibility Criteria
Inclusion Criteria: * Elevated or decreasing levels of cardiac troponin T, with at least one measurement exceeding 0.014 ng/mL; * Presence of at least one of the following: symptoms of myocardial ischemia; newly onset ischemic changes on ECG; pathological Q wave; imaging evidence of new loss of viable myocardium or regional wall motion abnormalities consistent with ischemia; coronary angiography confirming the presence of a thrombus; * Undergoing primary PCI; * Voluntary informed consent to participate in the study. Exclusion Criteria: * Inability to complete emergent PCI (e.g., due to intraoperative complications or inability to tolerate the procedure). * Prior administration of thrombolytic therapy before PCI. * Diagnosis of type 2 or type 3 myocardial infarction.
Contact & Investigator
Chunfeng Dai, M.D.
PRINCIPAL INVESTIGATOR
Fudan University
Frequently Asked Questions
Who can join the NCT07400601 clinical trial?
This trial is open to participants of all sexes, studying Acute Myocardial Infarction (AMI). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07400601 currently recruiting?
Yes, NCT07400601 is actively recruiting participants. Contact the research team at dai.chunfeng@zs-hospital.sh.cn for enrollment information.
Where is the NCT07400601 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT07400601 clinical trial?
NCT07400601 is sponsored by Shanghai Zhongshan Hospital. The principal investigator is Chunfeng Dai, M.D. at Fudan University. The trial plans to enroll 6,000 participants.